Metastatic Lung Cancer | Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum

published 1 month ago by Dr Neil Love

Proceedings from a CME symposium held during the IASLC 2019 North America Conference on Lung Cancer. Featuring perspectives from moderator Dr Joel W Neal and faculty members Drs Nasser H Hanna, Leora Horn and Lecia V Sequist: Introduction (00:00) Evolving Therapeutic Algorithms in Small Cell Lung Cancer (SCLC) (1:04) Optimal Therapeutic Approaches for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (21:55) Management of NSCLC with ALK Rearrangements (35:24) Current and Future Role of Existing and Emerging ROS1 Inhibitors (45:16) Treatment of Metastatic NSCLC with Other Targetable Tumor Mutations (56:06) Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other Systemic Therapies for Metastatic NSCLC (1:15:41) CME information and select publications

more episodes from Research To Practice | Oncology Videos